Autonomy Challenges in Epigenetic Risk-Stratified Cancer Screening: How Can Patient Decision Aids Support Informed Consent?

Information of an individual’s epigenome can be useful in cancer screening to enable personalised decision making on participation, treatment options and further screening strategies. However, adding this information might result in complex risk predictions on multiple diseases, unsolicited findings...

Descripción completa

Detalles Bibliográficos
Autores principales: Alblas, Maaike, Schermer, Maartje, Vergouwe, Yvonne, Bolt, Ineke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463084/
https://www.ncbi.nlm.nih.gov/pubmed/30781705
http://dx.doi.org/10.3390/jpm9010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463084/
https://www.ncbi.nlm.nih.gov/pubmed/30781705
http://dx.doi.org/10.3390/jpm9010014

Ejemplares similares